EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY-NC 4.0

Clinical Trial: Effect of a 28‐Day Low FODMAP Diet on Gastrointestinal Symptoms Associated With Endometriosis ( EndoFOD )—A Randomised, Controlled Crossover Feeding Study

Jane E Varney iD, Daniel So iD, Peter R Gibson iD, Dakota Rhys-Jones iD, Yuet Sang Jimmy Lee iD, Jane Fisher iD, Judith S Moore iD, Roni Ratner iD, Mark Morrison iD, Rebecca E Burgell iD, Jane G Muir iD

Alimentary Pharmacology & Therapeutics · 2025

DOI: 10.1111/apt.70161 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Alimentary Pharmacology & Therapeutics, 2025. Verfasst von Jane E Varney und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, School of Translational Medicine, Monash University and Alfred Health, Melbourne, Victoria, Australia. Hauptthemen laut MEDLINE: Endometriosis, Gastrointestinal Diseases, Diet, Carbohydrate-Restricted. Die Arbeit wurde bisher 28-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Medical Research Future Fund.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Gastrointestinal symptoms affect most women with endometriosis, but therapeutic interventions are poorly defined.

Aims

To compare the effects of a 28‐day low fermentable oligo‐, di‐ and mono‐saccharides and polyols (FODMAP) or control diet on gastrointestinal symptom severity in individuals with endometriosis and poorly controlled gastrointestinal symptoms.

Method

In this single‐blinded randomised, controlled cross‐over feeding trial, we randomised women aged ≥ 18 years to 28 days of either a low FODMAP (< 5 g/day FODMAPs) or control diet (20 g/day FODMAPs), both modelled on Australian Dietary Guidelines, before a ≥ 28‐day washout and crossover to the alternate diet. The primary outcome was the proportion of responders defined according to the response in overall gastrointestinal symptoms on a 100‐mm visual analogue scale. Secondary outcomes included gastrointestinal symptoms, quality of life and psychological status.

Results

Of 35 women randomised (mean age 31; 95% confidence interval 29, 33 years), 21 (60%) responded to the low FODMAP diet compared with 9 (26%) to the control diet ( p = 0.008). In the 4th week of the dietary intervention, overall symptom scores were 35 (21, 42) mm on the low FODMAP diet and 58 (55, 65) mm on the control diet ( p < 0.001). Abdominal pain, bloating, stool form and quality of life for both gastrointestinal and endometriosis‐associated scales were significantly better for the low FODMAP diet compared with the control diet, but not overall for perceived stress, anxiety or depression.

Conclusions

The low FODMAP diet ameliorates gastrointestinal symptoms related to endometriosis and improves quality of life. Confirmation of these findings in a real‐world setting is required. Trial Registration The trial is registered with the Australian New Zealand Clinical Trials Registry (ACTRN12621000153819).

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

EndometriosisGastrointestinal DiseasesDiet, Carbohydrate-RestrictedHumansFemaleCross-Over StudiesAdultQuality of LifeSingle-Blind MethodTreatment OutcomeYoung AdultPolymersAustraliaFODMAP Diet

Stichwörter der Autor:innen

dietendometriosisgastroenterologynutritionquality of life

Substanzen

Polymerspolyol

Autor:innen und Institutionen

  • Department of Gastroenterology, School of Translational Medicine, Monash University and Alfred Health, Melbourne, Victoria, Australia.
  • Public Health and Preventive Medicine, Monash University, Melbourne, Victoria, Australia.
  • Department of Obstetrics and Gynaecology, Monash University, Melbourne, Victoria, Australia.
  • Frazer Institute Faculty of Medicine, The University of Queensland., Brisbane, Queensland, Australia.

ORCID-Profile: Jane E Varney, Daniel So, Peter R Gibson, Dakota Rhys-Jones, Yuet Sang Jimmy Lee, Jane Fisher, Judith S Moore, Roni Ratner, Mark Morrison, Rebecca E Burgell, Jane G Muir

Förderung

  • Medical Research Future Fund

Zitieren

APA

Varney, J. E., So, D., Gibson, P. R., Rhys-Jones, D., Lee, Y. S. J., Fisher, J., Moore, J. S., Ratner, R., Morrison, M., Burgell, R. E., & Muir, J. G. (2025). Clinical Trial: Effect of a 28‐Day Low FODMAP Diet on Gastrointestinal Symptoms Associated With Endometriosis ( EndoFOD )—A Randomised, Controlled Crossover Feeding Study. Alimentary Pharmacology & Therapeutics. https://doi.org/10.1111/apt.70161

Vancouver

Varney JE, So D, Gibson PR, Rhys-Jones D, Lee YSJ, Fisher J, et al. Clinical Trial: Effect of a 28‐Day Low FODMAP Diet on Gastrointestinal Symptoms Associated With Endometriosis ( EndoFOD )—A Randomised, Controlled Crossover Feeding Study. Alimentary Pharmacology & Therapeutics. 2025. doi:10.1111/apt.70161

BibTeX
@article{Varney2025,
  author = {Varney, Jane E and So, Daniel and Gibson, Peter R and Rhys-Jones, Dakota and Lee, Yuet Sang Jimmy and Fisher, Jane and Moore, Judith S and Ratner, Roni and Morrison, Mark and Burgell, Rebecca E and Muir, Jane G},
  title = {Clinical Trial: Effect of a 28‐Day Low FODMAP Diet on Gastrointestinal Symptoms Associated With Endometriosis ( EndoFOD )—A Randomised, Controlled Crossover Feeding Study},
  journal = {Alimentary Pharmacology & Therapeutics},
  year = {2025},
  doi = {10.1111/apt.70161}
}
Kostenlos starten →